BLISS GVS PHARMA
Back to Balance Sheet
|
BLISS GVS PHARMA Last 5 Year Total Debt History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Debt | ₹71 Cr | ₹88 Cr | ₹98 Cr | ₹105 Cr | ₹119 Cr |
What is the latest Total Debt ratio of BLISS GVS PHARMA ?
| Year | Total Debt |
|---|---|
| Mar2025 | ₹71 Cr |
| Mar2024 | ₹88 Cr |
| Mar2023 | ₹98 Cr |
| Mar2022 | ₹105 Cr |
| Mar2021 | ₹119 Cr |
How is Total Debt of BLISS GVS PHARMA Trending?
| Years | Total Debt | % Change | |
|---|---|---|---|
| Mar2025 | ₹71 Cr | -19.17 | |
| Mar2024 | ₹88 Cr | -10.46 | |
| Mar2023 | ₹98 Cr | -6.56 | |
| Mar2022 | ₹105 Cr | -11.62 | |
| Mar2021 | ₹119 Cr | - | |
Compare Total Debt of peers of BLISS GVS PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| BLISS GVS PHARMA | ₹4,494.4 Cr | 41.5% | 57.7% | 213.6% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹432,096.0 Cr | -2.4% | 3% | 9.6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹176,807.0 Cr | -3.3% | 3.5% | 4.9% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹148,718.0 Cr | -2% | 5% | 43.1% | Stock Analytics | |
| CIPLA | ₹112,971.0 Cr | -0% | 6.9% | -4.5% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹108,752.0 Cr | -0.3% | -3.8% | 7.3% | Stock Analytics | |
BLISS GVS PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| BLISS GVS PHARMA | 41.5% |
57.7% |
213.6% |
| SENSEX | -0.5% |
-3.3% |
-7.6% |
You may also like the below Video Courses